“Transthyretin Silencing Therapies and the Cardiology Clinic: Selection, Cost and the Diagnostic Bottleneck Upstream”, JHCS, vol. 4, no. 1, pp. 1–4, Nov. 2023, doi: 10.5281/zenodo.22345291.